Smilow Cancer Center

New Haven, Connecticut 06519

1 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma, Pancreatic Ductal, Advanced Solid Tumor, Ampullary Adenocarcinoma, Breast Cancer, Chemotherapy Induced Peripheral Neuropathy, Duodenal Adenocarcinoma, Esophageal Adenocarcinoma, Foregut Adenocarcinoma, Gallbladder Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Hepatocellular Carcinoma

Studies at this site

• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
• Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels — Recruiting now
• Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors — Recruiting now
• Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients — Completed
• Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer — Completed
• A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma — Stopped early
• Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors — Stopped early
• A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter — Withdrawn before enrolling
• Randomized Phase II Trial of Chemoembolization and Sorafenib — Withdrawn before enrolling
• Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer — Completed